Study Enrollment

Your details will not be published or shared.

Clinical Trial

(ALPINE2) Randomized, Double-Blind, Phase 3B Trial to Evaluate the Safety and Efficacy of 2 Treatment Regimens of Aztreonam 75 mg Powder and Solvent for Nebulizer Solution / Aztreonam for Inhalation Solution (AZLI) in Pediatric Subjects with Cystic Fibrosis (CF) and New Onset Respiratory Tract Pseudomonas aeruginosa (PA) Infection/Colonization [Aztreonam Lysine for Pseudomonas INfection Eradication 2 (ALPINE 2) Study]

This study is for children who have cystic fibrosis and come down with a pseudomonas lung infection. It will test two different ways of using the drug Aztreonam to see which way works better.

Eligibility Criteria

  • Children under the age of 18 years Documented diagnosis of Cystic Fibrosis New diagnosis of Pseudomonas aeruginosa (PA) Infection

Contact Information

    Kathleen T. McKie, MD

    706 721-2635